Presentation TCT 2014 Updates from PARTNER 2A and Sapien 3 in Intermediate-Risk Patients Presenter: Martin B. Leon, Neil E. Moat, Ariel Finkelstein, Vinod H. Thourani September 13, 2014
Presentation TCT 2014 PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis Presenter: Patrick W. Serruys, David J. Cohen, Samir R. Kapadia September 13, 2014
News Conference News TCT 2014 PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients Yael L. Maxwell September 13, 2014
News Industry News 5 Year Data from Clinical Trial Studying TAVR in Patients with Severe Aortic Stenosis Demonstrates Persistent Mortality Benefit and Lower Rate of Repeat Hospitalizations Compared to Standard Therapy September 13, 2014
News Industry News Significant Patient Benefits With Edwards SAPIEN Valve Demonstrated In 5-Year PARTNER Trial Data September 13, 2014
News Industry News Ongoing enrollment in the first-in-man trial of CARMAT’s bioprosthetic heart September 08, 2014
News Conference News ESC 2014 FRANCE2: Registry Shows Positive Outcomes for TAVR in High-Risk Diabetic Patients Yael L. Maxwell September 02, 2014
News Daily News Low Trial Participation Rate of MI Patients Raises Questions of Applicability Todd Neale September 02, 2014
News Daily News Transfemoral TAVR Carries Similar Vascular Complication Risk With or Without Surgical Cutdown Todd Neale July 24, 2014
News Daily News La TAVR Transfemoral acarrea un Riesgo Similar de Complicaciones Vasculares Con o Sin Disección Quirúrgica Todd Neale July 24, 2014
News Daily News PARTNER Analiza las Curvas de Mortalidad Post-TAVR Más Destacadas Caitlin E. Cox July 17, 2014
News Daily News Una Mayor Regresión Precoz de la Masa VI Post-TAVR Reduce las Rehospitalizaciones June 27, 2014
News Features Advocacy Group Blasts Mobile Cardiovascular Screening Company for ‘Unethical’ Practices Yael L. Maxwell June 27, 2014